Spain High Potency Active Pharmaceutical Ingredients Market Size & Outlook

The high potency active pharmaceutical ingredients market in Spain is expected to reach a projected revenue of US$ 916.9 million by 2030. A compound annual growth rate of 6.8% is expected of Spain high potency active pharmaceutical ingredients market from 2024 to 2030.
Revenue, 2023 (US$M)
$579.6
Forecast, 2030 (US$M)
$916.9
CAGR, 2024 - 2030
6.8%
Report Coverage
Spain

Spain high potency active pharmaceutical ingredients market, 2018-2030 (US$M)

Spain

Related Markets

Spain high potency active pharmaceutical ingredients market highlights

  • The Spain high potency active pharmaceutical ingredients market generated a revenue of USD 579.6 million in 2023 and is expected to reach USD 916.9 million by 2030.
  • The Spain market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
  • In terms of segment, synthetic was the largest revenue generating product in 2023.
  • Biotech is the most lucrative product segment registering the fastest growth during the forecast period.


High potency active pharmaceutical ingredients market data book summary

Market revenue in 2023USD 579.6 million
Market revenue in 2030USD 916.9 million
Growth rate6.8% (CAGR from 2023 to 2030)
Largest segmentSynthetic
Fastest growing segmentBiotech
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSynthetic, Biotech
Key market players worldwideBasf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG


Other key industry trends

  • In terms of revenue, Spain accounted for 2.2% of the global high potency active pharmaceutical ingredients market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany high potency active pharmaceutical ingredients market is projected to lead the regional market in terms of revenue in 2030.
  • Russia is the fastest growing regional market in Europe and is projected to reach USD 682.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

High Potency Active Pharmaceutical Ingredients Market Scope

High potency active pharmaceutical ingredients market segmentation & scope
Synthetic
Biotech
In house
Outsourced
Innovative
Generic
Oncology
Hormonal
Glaucoma
Other Applications

High Potency Active Pharmaceutical Ingredients Market Companies

Name Profile # Employees HQ Website

Spain high potency active pharmaceutical ingredients market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.


Synthetic was the largest segment with a revenue share of 73.69% in 2023. Horizon Databook has segmented the Spain high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.


Elderly population is more susceptible to conditions such as cancer, diabetes, obesity, and cardiovascular diseases, leading to greater demand on the healthcare infrastructure. However, presence of developed healthcare infrastructure, favorable reimbursement policies, and high demand for oncology drugs are anticipated to fuel the market growth.

In April 2020, AGC Chemicals announced that it is increasing the capacity of its synthetic API production. It also manufactures biopharmaceuticals and biologics. International investments in Spain’s biotechnology ecosystem are also growing. For instance, in 2015, Sanifit received over EUR 36 million international investment.

Even during the COVID-19 pandemic, Spain pharmaceutical sector is getting high investments, which is anticipated to positively influence high potency active pharmaceutical ingredients market. The number of new cases of cancer is estimated to surpass 270,363 annually. Thus, rising number of cancer cases is expected to drive the market growth.

Reasons to subscribe to Spain high potency active pharmaceutical ingredients market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain high potency active pharmaceutical ingredients market databook

  • Our clientele includes a mix of high potency active pharmaceutical ingredients market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Spain high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain high potency active pharmaceutical ingredients market size, by product, 2018-2030 (US$M)

Spain High Potency Active Pharmaceutical Ingredients Market Outlook Share, 2023 & 2030 (US$M)

Spain high potency active pharmaceutical ingredients market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more